Validation of two models to estimate the probability of malignancy in patients with solitary pulmonary nodules

Thorax

Volumn 63, Issue 4, 2008, Pages 335-341

  Schultz, E M ^a,e   Sanders, G D ^b   Trotter, P R ^b   Patz Jr , E F ^b   Silvestri, G A ^c   Owens, D K ^a,d   Gould, M K ^a,d  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^e STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER LOCALIZATION; CANCER SIZE; CIGARETTE SMOKING; COMPARATIVE STUDY; CONFIDENCE INTERVAL; DIAGNOSTIC ACCURACY; EXPERIMENTAL MODEL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LUNG NODULE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; PROBABILITY; RECEIVER OPERATING CHARACTERISTIC; STATISTICAL SIGNIFICANCE; VALIDATION STUDY;

ADULT; AGED; AGED, 80 AND OVER; COIN LESION, PULMONARY; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PREDICTIVE VALUE OF TESTS; PROBABILITY; RETROSPECTIVE STUDIES; ROC CURVE;

EID: 41849097085     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2007.084731     Document Type: Article

References (15)

1. Ost D, Fein AM, Feinsilver SH. Clinical practice. The solitary pulmonary nodule. N Engl J Med 2003;348:2535-42.
2. Tan BB, Flaherty KR, Kazerooni EA, et al. The solitary pulmonary nodule. Chest 2003;123:89-96S.
3. Cummings SR, Lillington GA, Richard RJ. Managing solitary pulmonary nodules. The choice of strategy is a "close call". Am Rev Respir Dis 1986;134:453-60.
4. Dietlein M, Weber K, Gandjour A, et al. Cost-effectiveness of FDG-PET for the management of solitary pulmonary nodules: a decision analysis based on cost reimbursement in Germany. Eur J Nucl Med 2000;27:1441-56.
5. Gambhir SS, Shepherd JE, Shah BD, et al. Analytical decision model for the cost-effective management of solitary pulmonary nodules. J Clin Oncol 1998;16:2113-25.
6. Gould MK, Sanders GD, Barnett PG, et al. Cost-effectiveness of alternative management strategies for patients with solitary pulmonary nodules. Ann Intern Med 2003;138:724-35.
7. Swensen SJ, Silverstein MD, Ilstrup DM, et al. The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules. Arch Intern Med 1997;157:849-55.
8. Gould MK, Ananth L, Barnett PG. A clinical model to estimate the pre-test probability of lung cancer in patients with solitary pulmonary nodules. Chest 2007;131:383-8.
9. Henschke CI, Yankelevitz DF, Mateescu I, et al. Neural networks for the analysis of small pulmonary nodules. Clin Imaging 1997;21:390-9.
10. Matsuki Y, Nakamura K, Watanabe H, et al. Usefulness of an artificial neural network for differentiating benign from malignant pulmonary nodules on high-resolution CT: evaluation with receiver operating characteristic analysis. AJR Am J Roentgenol 2002;178:657-63.
11. Nakamura K, Yoshida H, Engelmann R, et al. Computerized analysis of the likelihood of malignancy in solitary pulmonary nodules with use of artificial neural networks. Radiology 2000;214:823-30.
12. Thompson EM, Sanders GD, Trotter PR, et al. Validation of a decision model for managing solitary pulmonary nodules [abstract]. Am J Respir Crit Care Med 2007;175:A869.
13. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36.
14. Davison AC, Hinkley DV. Bootstrap methods and their application. New York: Cambridge University Press, 1997.
15. Herder GJ, van Tinteren H, Golding RP, et al. Clinical prediction model to characterize pulmonary nodules: validation and added value of 18-F-fluorodeoxyglucose positron emission tomography. Chest 2005;128:2490-6.